NYSE:ZTS Zoetis (ZTS) Stock Price, News & Analysis $85.56 +2.08 (+2.49%) Closing price 03:59 PM EasternExtended Trading$85.83 +0.27 (+0.32%) As of 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Zoetis Stock (NYSE:ZTS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Zoetis alerts:Sign Up Key Stats Today's Range$82.15▼$86.5850-Day Range$69.07▼$88.6052-Week Range$68.77▼$132.49Volume4.66 million shsAverage Volume5.43 million shsMarket Capitalization$34.76 billionP/E Ratio14.55Dividend Yield2.48%Price Target$101.25Consensus RatingHold Company Overview Zoetis is an animal health company that discovers, develops, manufactures and markets medicines, vaccines, diagnostic products and other services for animals. Its products support both companion animals, such as dogs and cats, and livestock, including cattle, pigs, poultry, sheep and fish. The company’s offerings include treatments for pain, infections and skin conditions, as well as vaccines, parasiticides, diagnostic tools and genetic testing services. Zoetis serves veterinarians, livestock producers and other animal health professionals around the world. Zoetis originated as Pfizer’s animal health business and became an independent public company in 2013. The company is headquartered in Parsippany, New Jersey, and is led by Chief Executive Officer Kristin Peck.AI Generated. May Contain Errors. Read More Zoetis Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks86th Percentile Overall ScoreZTS MarketRank™: 4.30784708249 of 5 starsZoetis scored higher than 86% of companies evaluated by MarketBeat, and ranked 87th out of 1,706 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingHold Consensus RatingZoetis has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 8 buy ratings, 12 hold ratings, and 1 sell rating.Upside PotentialZoetis has a consensus price target of $101.25, representing about 18.3% upside from its current price of $85.56.Amount of Analyst CoverageZoetis has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Zoetis' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth0.95% Earnings GrowthEarnings for Zoetis are expected to grow by 0.95% in the coming year, from $6.29 to $6.35 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Zoetis is 14.55, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.92.Price to Earnings Ratio vs. SectorThe P/E ratio of Zoetis is 14.55, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 33.58.Price to Earnings Growth RatioZoetis has a PEG Ratio of 1.22. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioZoetis has a P/B Ratio of 10.52. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.06% of the float of Zoetis has been sold short.Short Interest Ratio / Days to CoverZoetis has a short interest ratio ("days to cover") of 4.78.Change versus previous monthShort interest in Zoetis has recently decreased by 4.55%, indicating that investor sentiment is improving. Dividend4.2 / 5Dividend StrengthStrong Dividend YieldZoetis pays a meaningful dividend of 2.51%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthZoetis has been increasing its dividend for 14 years.Dividend CoverageThe dividend payout ratio of Zoetis is 36.05%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Zoetis will have a dividend payout ratio of 33.39% next year. This indicates that Zoetis will be able to sustain or increase its dividend.Read more about Zoetis' dividend. News and Social Media2.1 / 5News Sentiment0.38 News SentimentZoetis has a news sentiment score of 0.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Zoetis this week, compared to 8 articles on an average week.Search InterestOnly 8 people have searched for ZTS on MarketBeat in the last 30 days. This is a decrease of -62% compared to the previous 30 days.MarketBeat Follows10 people have added Zoetis to their MarketBeat watchlist in the last 30 days. This is an increase of 67% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Zoetis insiders have not sold or bought any company stock.Percentage Held by Insiders0.22% of the stock of Zoetis is held by insiders.Percentage Held by Institutions92.80% of the stock of Zoetis is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Zoetis' insider trading history. Receive ZTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Zoetis and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ZTS Stock News HeadlinesZoetis Inc. stock underperforms Tuesday when compared to competitorsNovember 18 at 8:59 AM | marketwatch.comETFs Are Net Sellers of Zoetis (ZTS) on MondayNovember 18 at 8:59 AM | finance.yahoo.comBuy Stocks… A Crash is ComingThink stocks are expensive and a crash is coming? Economist Jim Rickards says you're right, but he urges investors not to sell before hearing his 2027 prediction. He warns that by November 30th, Congress is set to make a move he believes will trigger a historic buying panic. Economists call the phenomenon a crack-up boom. Rickards is known for correctly predicting the biggest market shocks of the last 20 years.November 18 at 1:00 AM | Paradigm Press (Ad)Zoetis Braces for Weak Vet Visits, Bets on New Products for GrowthNovember 18 at 1:14 AM | americanbankingnews.comZoetis Inc. (ZTS) Presents at Jefferies Global Healthcare Conference 2026 TranscriptNovember 16 at 12:18 PM | seekingalpha.comWhat are Wall Street analysts' target price for Zoetis stock?November 11, 2026 | msn.comZoetis Receives USDA License for Cytopoint Plus™: The First and Only Long-Acting Monoclonal Antibody Providing 75 Days of Allergic Itch Relief in Dogs with Allergic DermatitisNovember 11, 2026 | businesswire.comAnalysts’ Opinions Are Mixed on These NA Stocks: Strategy (MSTR), Zoetis (ZTS) and Mosaic Co (MOS)November 10, 2026 | theglobeandmail.comSee More Headlines ZTS Stock Analysis - Frequently Asked Questions How have ZTS shares performed this year? Zoetis' stock was trading at $125.82 at the beginning of 2026. Since then, ZTS stock has decreased by 32.0% and is now trading at $85.5570. How were Zoetis' earnings last quarter? Zoetis Inc. (NYSE:ZTS) announced its earnings results on Thursday, November, 5th. The company reported $1.75 EPS for the quarter, beating the consensus estimate of $1.51 by $0.24. The business's revenue for the quarter was down 1.3% on a year-over-year basis. Read the conference call transcript. Does Zoetis have any subsidiaries? Zoetis subsidiaries include these companies: Jorox Pty, Virtual Recall, Fish Vet Group, Performance Livestock Analytics, Ethos Diagnostic Science, ZNLabs, Phoenix Lab, and more. When did Zoetis IPO? Zoetis (ZTS) raised $2.3 billion in an initial public offering on Friday, February 1st 2013. The company issued 99,015,000 shares at $22.00-$25.00 per share. Who are Zoetis' major shareholders? Zoetis' top institutional shareholders include State Street Corp (4.85%), Banque Pictet & Cie SA (0.43%), Worldquant Millennium Advisors LLC (0.26%) and Sumitomo Mitsui Trust Group Inc. (0.22%). Insiders that own company stock include Kristin C Peck, Paul Bisaro, Michael B Mccallister, Frank A Damelio, Roxanne Lagano and Willie M Reed. View institutional ownership trends. How do I buy shares of Zoetis? Shares of ZTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Zoetis own? Based on aggregate information from My MarketBeat watchlists, some other companies that Zoetis investors own include NVIDIA (NVDA), Visa (V), Salesforce (CRM), Home Depot (HD), Advanced Micro Devices (AMD), Adobe (ADBE) and Mastercard (MA). Company Calendar Record date for 9/1 Dividend7/20/2026Ex-Dividend for 9/1 Dividend7/20/2026Dividend Payable9/01/2026Record date for 12/1 Dividend10/30/2026Ex-Dividend for 12/1 Dividend10/30/2026Last Earnings11/05/2026Today11/18/2026Dividend Payable12/01/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2d) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 As of 2 days ago, ZTS's financial health entered the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNYSE:ZTS CIK1555280 Webwww.zoetis.com Phone(973) 822-7000Fax302-655-5049Employees14,500Year Founded1952Price Target and Rating Average Price Target for Zoetis$101.25 High Price Target$155.00 Low Price Target$74.00 Potential Upside/Downside+18.3%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage21 Analysts Profitability EPS (Trailing Twelve Months)$5.88 Trailing P/E Ratio14.55 Forward P/E Ratio13.47 P/E Growth1.22Net Income$2.67 billion Net Margins26.15% Pretax Margin33.05% Return on Equity85.90% Return on Assets18.39% Debt Debt-to-Equity Ratio2.51 Current Ratio2.35 Quick Ratio1.40 Sales & Book Value Annual Sales$9.47 billion Price / Sales3.67 Cash Flow$7.67 per share Price / Cash Flow11.15 Book Value$8.13 per share Price / Book10.52Miscellaneous Outstanding Shares406,320,000Free Float405,422,000Market Cap$34.76 billion OptionableOptionable Beta0.67 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NYSE:ZTS) was last updated on 11/18/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zoetis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zoetis With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.